PUBLIC COMPANY
saveJanssen-Cilag Holdings Inc (Inactive)
updated 2mo ago
community read0 votes
pipeline
3
marketed
3
phase 3
0
catalysts ytd
7
approvals ytd
7
recalls ytd
0
Pipeline(3)
pipeline depth3 products
3Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- —A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis
- phase3A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
- —A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide
- phase3Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
- —A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants
- —A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
- —A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)
- —A Real-world Study in Participants With Smoldering Multiple Myeloma
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that